Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2787-2793

  Lazar, Amy D ^a   Winter, Michael R ^a   Nogueira, Christine P ^a   Larson, Pamela S ^a   Finnemore, Erin M ^a   Dolan, Robert W ^a   Fuleihan, Nabil ^a   Chakravarti, Arnab ^a   Zietman, Anthony ^a   Rosenberg, Carol L ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHROMOSOME 11Q; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS;

EID: 0031786095     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Shah, J. P., and Lydiatt, W. Treatment of cancer of the head and neck. CA Cancer J. Clin., 45: 352-368, 1995.
2. Field, J. K. Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Eur. J. Cancer, 28: 67-76, 1992.
3. Field, J. K., Kiaris, H., Risk, J. M., Tsiriyotis, C., Adamson, R., Zoumporlis, V., Rowley, H., Taylor, K., Whittaker, J., Howard, P., Beirne, J. C., Gosney, J. R., Woolgar, J., Vaughn, E. D., Spandidos, D. A., and Jones, A. S. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br. J. Cancer, 72: 1180-1188, 1995.
4. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
5. Ah-See, K. W., Cooke, T. G., Pickford, I. R., Sautar, D., and Balmain, A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54: 1617-1621, 1994.
6. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152-1155, 1994.
7. Carter, S. L., Negrini, M., Baffa, R., Gillum, D. R., Rosenberg, A. L., Schwartz, G. F., and Croce, C. M. Loss of heterozygosity at 11q22-23 in breast cancer. Cancer Res., 54: 6270-6274, 1994.
8. Gabra, H., Taylor, L., Cohen, B., Lessels, A., Eccles, D., Leonard, R., Smyth, J., and Steel, C. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br. J. Cancer, 72: 367-375, 1995.
9. Rasio, D., Negrini, M., Manenti, G., Dragani, T. A., and Croce, C. M. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res., 55: 3988-3991, 1995.
10. Iizuka, M., Sugiyama, Y., Shiraishi, M., Jones, C., and Sekiya, T. Allelic losses in human chromosome 11 in lung cancers. Genes Chromosomes Cancer, 13: 40-46, 1995.
11. Herbst, R. A., Larson, A., Weiss, J., Cavanee, W. K., Hampton, G. M., and Arden, K. C. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res., 55: 2494-2496, 1995.
12. Rader, J., Kamarasova, T., Huettner, P., Li, L., Li, Y., and Gerhard, D. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene, 13: 2737-2741, 1996.
13. Baffa, R., Negrini, M., Mandes, B., Rugge, M., Ranzani, G., Hirohashi, S., and Croce, C. M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res., 56: 268-272, 1996.
14. Hui, A. B. Y., Lo, K-W., Leung, S-f., Choi, P. H. K., Fong, Y., Lee, J. C. K., and Huang, D. P. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res., 56: 3225-3229, 1996.
15. Nogueira, C. P., Dolan, R. W., Gooey, J., Byahatti, S., Vaughn, C. W., Fuleihan, N. S., Grillone, G., Baker, E., and Domanowski, G. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope, 108: 345-350, 1998.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 9.16-9.21. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749-1753, 1995.
18. Kastan, M. B., Onyejwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of the p53 protein in the cellular response to DNA damage. Cancer Res., 57: 6304-6311, 1991.
19. Harris, C. C., and Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329: 1318-1327, 1993.
20. Pirollo, K. F., Hao, Z., Rait, A., Jang, Y. J., Fee, W. E. J., Ryan, P., Chiang, Y., and Chang, E. H. P53-mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene, 14: 1735-1746, 1997.
21. Gudmundsson, J., Barkardottir, R., Eiriksdottir, G., Baldursson, T., Arason, A., Egilsson, V., and Ingvarsson, S. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br. J. Cancer, 72: 696-701, 1995.
22. Winqvist, R., Hampton, G., Mannermaa, A., Blanco, G., Alavaikko, M., Kiviniemi, H., Taskinen, P., Evans, G., Wright, F., Newsham, I., and Cavanee, W. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55: 2660-2664, 1995.
23. Gabra, H., Watson, J. E. V., Taylor, K. J., Mackay, J., Leonard, R. C. F., Steel, M., Porteous, D. J., and Smyth. J. F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res., 56: 950-954, 1996.
24. Callender, T., el-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
25. Muller, D., Millon, R., Lidereau, R., Engelmann, A., Bronner, G., Flesh, H., Eber, M., Methlin, G., and Abecassis, J. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer, 2: 113-120, 1994.
26. Parise, O. J., Janot, F., Guerry, R., Fortin, A., Luboinski, B., Tursz, T., Schwaab, G., and Busson, P. Chromosome 11q13 amplifications in head and neck squamous cell carcinomas: relation with lymph node invasion. Int. J. Oncol., 5: 309-313, 1994.
27. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
28. Akervall, J. A., Michalides, R. J. A. M., Mineta, H., Balm, A., Borg, A., Dictor, M. R., Hin, Y., Loftus, B., Mertens, F., and Wennerberg, J. P. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila.), 79: 380-389, 1997.
29. Capaccio, P., Pruneri, G., Carboni, N., Pagliari, A. V., Buffa, R., Neri, A., Ottaviani, A., and Pignataro, L. Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J. Laryngol. Otol., 111: 622-626, 1997.
30. Michalides, R. J., van Veelen, N. M., Kristel, P. M., Hart, A. A., Loftus, B. M., Hilgers, F. J., and Balm, A. J. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 123: 497-502, 1997.
31. Wennerberg, J. Predicting response to therapy of squamous cell carcinoma of the head and neck. Anticancer Res., 16: 2389-2396, 1996.
32. Raybaud-Diogene, H., Fortin, A., Morency, R., Roy, J., Monteil, R. A., and Tetu, B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J. Clin. Oncol., 75: 1030-1038, 1997.
33. Kokoska, M. S., Piccirillo, J. F., el-Mofty, S. K., Emami, B., Haughey, B. H., and Scholnick, S. B. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer (Phila.), 78: 1693-1700, 1996.
34. Wilson, G. D., Richman, P. I., Dische, S., Saunders, M. I., Robinson, B., Daley, F. M., and Ross, D. A. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. Br. J. Cancer, 71: 1248-1252, 1995.
35. Koch, W. M., Brennan, J. A., Zahurak, M., Goodman, S. N., Westra, W. H., Schwab, D., Yoo, G. H., Lee, D. J., Forastiere, A. A., and Sidransky, D. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J. Natl. Cancer Inst., 88: 1580-1586, 1996.
36. Olshan, A. F., Weissler, M. C., Pei, H., Conway, K., Anderson, S., Fried, D. B., and Yarbrough, W. G. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene, 14: 811-818, 1997.
37. Miyakoshi, J., Kitigawa, K., Yamagishi, N., Ohtsu, S., Day, R. S. R. and Takebe, H. Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene. Jpn. J. Cancer Res., 88: 34-38, 1997.
38. Meyn, M. S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res., 55: 5991-6001, 1995.
39. Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., and Leder, P. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet., 16: 397-401, 1997.